Akkermansia muciniphila is a beneficial gut bacterium that supports metabolic health, gut integrity, and immune function. Low levels have been associated with obesity, diabetes, heart disease, and “leaky gut.” Research shows that Akkermansia influences GLP-1 (glucagon-like peptide-1), a hormone that reduces appetite and helps regulate blood sugar levels. This effect is similar to GLP-1-based medications like Ozempic, commonly used to manage type 2 diabetes and obesity.

Due to factors like age, repeated antibiotic use, and diets low in fiber and polyphenols, Akkermansia levels can decline. Testing provides insights into whether your levels are optimal, helping you determine if dietary adjustments or supplements could support your health.